The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 254 participants.

Also called NCT02452502

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 254 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02452502
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02452502. Randomized; no masking; primary purpose treatment. Start 2015-09-02 (actual); primary completion 2017-11 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Safety and Efficacy Study of High Dose Atorvastatin After Thrombolytic Treatment in Acute Ischemic Stroke
Acronym
SEATIS
Condition
Stroke
Intervention (Device)
atorvastatin
Lead sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine (class: other)
Collaborator
The First Hospital of Jilin University (class: other)

Record details

Record id
cardio:ct-nct02452502
Content hash
7b6dff4a5bad8a2654a5b4fd016abef4aab3eb4b9cc2e93c5fb1b87d9e2e990d